These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 9237797

  • 1. Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines.
    Polanski M, Melican NS, Zhang J, Weiner HL.
    J Autoimmun; 1997 Aug; 10(4):339-46. PubMed ID: 9237797
    [Abstract] [Full Text] [Related]

  • 2. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R, Melican NS, Weiner HL.
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [Abstract] [Full Text] [Related]

  • 3. Insulin in oral immune "tolerance": a one-amino acid change in the B chain makes the difference.
    Homann D, Dyrberg T, Petersen J, Oldstone MB, von Herrath MG.
    J Immunol; 1999 Aug 15; 163(4):1833-8. PubMed ID: 10438916
    [Abstract] [Full Text] [Related]

  • 4. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes.
    Bergerot I, Fabien N, Maguer V, Thivolet C.
    J Autoimmun; 1994 Oct 15; 7(5):655-63. PubMed ID: 7840857
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS, Balasa B, Davies JD, Sarvetnick N.
    J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077
    [Abstract] [Full Text] [Related]

  • 6. Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage.
    Franco L, Benedetti R, Ferek GA, Massouh E, Fló J.
    Cell Immunol; 1998 Nov 25; 190(1):1-11. PubMed ID: 9826441
    [Abstract] [Full Text] [Related]

  • 7. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ.
    Diabetes; 2007 Aug 25; 56(8):2116-23. PubMed ID: 17496235
    [Abstract] [Full Text] [Related]

  • 8. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.
    Daniel D, Gill RG, Schloot N, Wegmann D.
    Eur J Immunol; 1995 Apr 25; 25(4):1056-62. PubMed ID: 7537670
    [Abstract] [Full Text] [Related]

  • 9. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
    Gong Z, Pan L, Le Y, Liu Q, Zhou M, Xing W, Zhuo R, Wang S, Guo J.
    Vaccine; 2010 May 28; 28(24):4052-8. PubMed ID: 20406664
    [Abstract] [Full Text] [Related]

  • 10. Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice.
    Tian J, Chau C, Kaufman DL.
    Diabetologia; 1998 Feb 28; 41(2):237-40. PubMed ID: 9498660
    [Abstract] [Full Text] [Related]

  • 11. Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice.
    Urbanek-Ruiz I, Ruiz PJ, Paragas V, Garren H, Steinman L, Fathman CG.
    Clin Immunol; 2001 Aug 28; 100(2):164-71. PubMed ID: 11465945
    [Abstract] [Full Text] [Related]

  • 12. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain.
    Schloot NC, Willemen S, Duinkerken G, de Vries RR, Roep BO.
    J Autoimmun; 1998 Apr 28; 11(2):169-75. PubMed ID: 9650096
    [Abstract] [Full Text] [Related]

  • 13. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
    Wilson SS, DeLuca D.
    J Autoimmun; 1997 Oct 28; 10(5):461-72. PubMed ID: 9376074
    [Abstract] [Full Text] [Related]

  • 14. Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant.
    Hartmann B, Bellmann K, Ghiea I, Kleemann R, Kolb H.
    Diabetologia; 1997 Aug 28; 40(8):902-9. PubMed ID: 9267984
    [Abstract] [Full Text] [Related]

  • 15. Regulation of pulmonary T cell responses to inhaled antigen: role in Th1- and Th2-mediated inflammation.
    Lee SC, Jaffar ZH, Wan KS, Holgate ST, Roberts K.
    J Immunol; 1999 Jun 01; 162(11):6867-79. PubMed ID: 10352309
    [Abstract] [Full Text] [Related]

  • 16. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
    Maron R, Guerau-de-Arellano M, Zhang X, Weiner HL.
    J Autoimmun; 2001 Feb 01; 16(1):21-8. PubMed ID: 11221993
    [Abstract] [Full Text] [Related]

  • 17. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
    Heurtier AH, Boitard C.
    Diabetes Metab; 1997 Nov 01; 23(5):377-85. PubMed ID: 9416429
    [Abstract] [Full Text] [Related]

  • 18. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
    Jaakkola I, Jalkanen S, Hänninen A.
    Eur J Immunol; 2003 Dec 01; 33(12):3255-64. PubMed ID: 14635033
    [Abstract] [Full Text] [Related]

  • 19. Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope.
    Alleva DG, Maki RA, Putnam AL, Robinson JM, Kipnes MS, Dandona P, Marks JB, Simmons DL, Greenbaum CJ, Jimenez RG, Conlon PJ, Gottlieb PA.
    Scand J Immunol; 2006 Jan 01; 63(1):59-69. PubMed ID: 16398702
    [Abstract] [Full Text] [Related]

  • 20. Regulatory role of pro-Th1 and pro-Th2 cytokines in modulating the activity of Th1 and Th2 cells when B cell and macrophages are used as antigen presenting cells.
    Singh V, Agrewala JN.
    BMC Immunol; 2006 Aug 07; 7():17. PubMed ID: 16889674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.